SEPTEMBER 2023 / NOSTRUM & NAVIGO: RESEARCH COLLABORATION
We are excited to announce a pioneering partnership between Nostrum Biodiscovery, a frontrunner in computational molecular engineering services, and Navigo Proteins, an innovator developing next generation targeting ligands called Affilin®.
RESEARCH COLLABORATION
Navigo and Nostrum recently joined forces to co-develop a new cutting-edge pipeline of de novo designed ubiquitin-based Affilin® ligands, expanding Navigo’s proprietary Affilin® technology. With a small size, excellent stability, and high modularity, Affilin® are ideally suited for developing next-generation targeted therapeutics, like Affilin®- based radiotheranostics, drug conjugates and more.
Combining artificial intelligence (AI) and molecular modelling (MM) tools with the Affilin® discovery platform, the collaboration aims to enhance the efficiency of developing novel binders with high affinity and specificity to a target protein. The concept relies on smartly designing sequences based on Navigo’s proprietary database, and then accurately predicting the fitness with MM approaches.
More Info Here
#science #research #DrugDesign #DrugDiscovery #pharmacology #NBDSuite #MolecularModeling #ArtificialIntelligence #research
